Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential
Author(s) -
Thomas P. Monath,
Richard Nichols,
Lynda Tussey,
Kelly Scappaticci,
Thaddeus G. Pullano,
Mary D. Whiteman,
Nikos Vasilakis,
Shannan L. Rossi,
Rafael K. Campos,
Sasha R. Azar,
Heidi Spratt,
Brent L. Seaton,
W. Tad Archambault,
Yanina V. Costecalde,
Evan H. Moore,
Roger Hawks,
Joan Fusco
Publication year - 2022
Publication title -
plos pathogens
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.719
H-Index - 206
eISSN - 1553-7374
pISSN - 1553-7366
DOI - 10.1371/journal.ppat.1010658
Subject(s) - virology , vesicular stomatitis virus , ebola virus , biology , virus , attenuated vaccine , vesicular stomatitis , rabies , virulence , ebola vaccine , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom